期刊文献+

经尿道前列腺等离子电切术联合剜除术在前列腺增生症患者中的应用及对MCP-1和PDGF-BB表达的影响研究 被引量:21

The application of transurethral resection of prostate and enucleation in patients with benign prostatic hyperplasia and its effect on MCP-1 and PDGF-BB expression
下载PDF
导出
摘要 目的:分析经尿道前列腺等离子电切术联合剜除术治疗前列腺增生的临床疗效及对单核细胞趋化因子-1(MCP-1)、血小板衍生生长因子BB(PDGF-BB)的影响,为临床前列腺增生患者治疗方案的选择提供参考。方法:选择2015年1月至2017年1月华北理工大学附属医院收治的前列腺增生患者86例作为研究对象,根据就诊顺序编号,采用数字随机表法将其分为两组,每组43例。一组采用经尿道前列腺等离子电切术联合剜除术治疗,设为观察组;一组采用经尿道前列腺等离子电切术治疗,设为对照组。比较两组患者术后临床疗效、围术期并发症情况,术前、术后1周采集患者静脉血,采用疫荧光发分析MCP-1、PDGFBB的表达变化。结果:两组患者一般资料比较差异无统计学意义(P>0.05)。术后3个月进行临床疗效评价,观察组(IPSS、尿流率、残余尿)改善效果明显优于对照组,其差异具有统计学意义(P<0.05);比较两组患者术后并发症率,其差异无统计学意义(P>0.05)。比较两组患者术前血清MCP-1、PDGF-BB表达,其差异无统计学意义(P>0.05);术后一周,两组患者血清MCP-1、PDGF-BB均较术前明显降低,其差异具有统计学意义(P<0.05),且观察组MCP-1、PDGF-BB均低于对照组,其差异具有统计学意义(P<0.05)。结论:经尿道前列腺电切术联合剜除术可以有效提高前列腺增生患者的临床疗效,并不增加并发症率,且可以更有效地改善影响患者前列腺平滑肌异常增生的MCP-1、PDGF-BB水平,消除前列腺增生的发病原因。 Objective: To analyze the clinical efficacy of transurethral resection of prostate( TURP) and enucleation in the treatment of benign prostatic hyperplasia( BPH) and the effect on monocyte chemoattractant factor-1( MCP-1),platelet-derived growth factor-BB( PDGF-BB),in order to provide a reference for the treatment of BPH patients. Methods: 86 BPH patients treated in the Hospital Affiliated to North China University of Technology from January 2015 to January 2017 were selected and,according to the order of treatment,were divided into two groups randomly. The control group was treated by TURP,and the observation group was treated with TURP combined with enucleation. The clinical efficacy and perioperative complications of the two groups were compared. The venous blood was collected before and a week after operation. The expression of MCP-1 and PDGF-BB was detected by immunofluorescence. Results: There was no significant difference between the two groups in general information( P〉0. 05). Improvements in the IPSS,urinary flow rate and residual urine were significantly better in the observation group than those in the control group( P〈0. 05). There was no significant difference in the incidence of postoperative complication between the two groups. There was no significant difference in the expression of MCP-1 and PDGF-BB between the two groups( P〉0. 05). The levels of MCP-1 and PDGF-BB in the two groups were significantly lower than those before operation( P〈0. 05),and the levels of MCP-1 and PDGF-BB in the observation group were lower than those in the control group( P〈0. 05). Conclusions: TURP combined with enucleation can be used to improve the clinical curative effect for BPH and improve the level of MCP-1 and PDGF-BB,without increasing the complication rate,hereby eliminating the causes of BPH.
作者 王磊 么安亮 曹凤宏 张小军 张立国 张金存 康绍叁 FANG Lei;YAO Anliang;CAO Fenghong;ZHANG Xiaojun;ZHANG Liguo;ZHANG Jincun;KANG Shaosan(Department of Urology,The Hospital Affiliated to North China University of Technology,Tangshan 063000,Hebei,Chin)
出处 《中国性科学》 2018年第5期9-12,共4页 Chinese Journal of Human Sexuality
基金 河北省2017年度医学科学研究重点课题项目(20170906)
关键词 前列腺增生症 经尿道前列腺等离子电切术 前列腺剜除术 单核细胞趋化因子-1 血小板衍生生长因子-BB Benign prostatic hyperplasia (BPH) Transurethral resection of the prostate (TURP) Pros-tate enueleation Monoeyte ehemotaetie factor-1 (MCP-1) Platelet-derived growth faetor-BB (PDGF-BB)
  • 相关文献

参考文献13

二级参考文献105

共引文献341

同被引文献159

引证文献21

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部